{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:16:05Z","timestamp":1790702165782,"version":"4.1.0"},"reference-count":80,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>SENP1 (sentrin-specific protease 1) mediates sumoylation, a reversible post-translational modification that attaches the SUMO (small ubiquitin-like modifier) protein to target proteins. These modified proteins are essential in many key cellular processes, including cell cycle regulation, DNA repair, and apoptosis. Disruptions in the balance between sumoylated and desumoylated proteins can lead to various pathological conditions, such as cancer. Experimental data suggest that certain natural compounds, including momordin Ic (Mc), hinokiflavone (HNK), triptolide (TPL), ursolic acid (UA), streptonigrin (SN), vialinin A (VA), thelephantin G (TG), and others, effectively inhibit SENP1 activity, thereby influencing the levels of sumoylated proteins and cellular processes. This article reviews existing knowledge on the structure and function of natural SENP1 inhibitors, particularly their potential application in cancer therapy, including their capacity to overcome resistance to conventional chemotherapies. Some of the natural SENP1 inhibitors tested so far interact directly with the enzyme\u2019s active site. The current understanding of how this interaction occurs is also discussed.<\/jats:p>","DOI":"10.3390\/ijms262211210","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:44:53Z","timestamp":1763631893000},"page":"11210","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Naturally Derived SENP1 Inhibitors with Anticancer Activity"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0013-6832","authenticated-orcid":false,"given":"Renata","family":"Krupa","sequence":"first","affiliation":[{"name":"Department of Molecular Genetics, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141\/143, 90-236 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6666-7973","authenticated-orcid":false,"given":"Katarzyna","family":"Wo\u017aniak","sequence":"additional","affiliation":[{"name":"Department of Molecular Genetics, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141\/143, 90-236 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"ref_1","first-page":"1081","article-title":"The post-translational modification, SUMOylation, and cancer (Review)","volume":"52","author":"Han","year":"2018","journal-title":"Int. J. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.21775\/cimb.035.017","article-title":"Progress in the Discovery of Small Molecule Modulators of DeSUMOylation","volume":"35","author":"Chen","year":"2020","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.bbrc.2005.09.090","article-title":"A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation","volume":"337","author":"Owerbach","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1152\/physrev.00025.2019","article-title":"SUMO: From Bench to Bedside","volume":"100","author":"Chang","year":"2020","journal-title":"Physiol. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Lin, M., Zhang, M., Yi, B., Chen, J., Wen, S., Chen, R., Chen, T., and Li, Z. (2024). Emerging role of SENP1 in tumorigenesis and cancer therapy. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1354323"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1177\/1947601910382555","article-title":"SUMO Losing Balance: SUMO Proteases Disrupt SUMO Homeostasis to Facilitate Cancer Development and Progression","volume":"1","author":"Yeh","year":"2010","journal-title":"Genes Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"114650","DOI":"10.1016\/j.ejmech.2022.114650","article-title":"Recent research and development of inhibitors targeting sentrin-specific protease 1 for the treatment of cancers","volume":"241","author":"Wei","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.21037\/atm-21-6909","article-title":"SENP1 inhibition suppresses the growth of lung cancer cells through activation of A20-mediated ferroptosis","volume":"10","author":"Gao","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"113822","DOI":"10.1016\/j.yexcr.2023.113822","article-title":"SENP1-mediated SUMOylation of SIRT1 affects glioma development through the NF-\u03baB pathway","volume":"433","author":"Liu","year":"2023","journal-title":"Exp. Cell Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.18632\/aging.102700","article-title":"SENP1 is a crucial promotor for hepatocellular carcinoma through deSUMOylation of UBE2T","volume":"12","author":"Tao","year":"2020","journal-title":"Aging"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"16396","DOI":"10.1038\/srep16396","article-title":"SENP1 desensitizes hypoxic ovarian cancer cells to cisplatin by up-regulating HIF-1\u03b1","volume":"5","author":"Ao","year":"2015","journal-title":"Sci Rep."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/jcb.26342","article-title":"SENP1\/HIF-1\u03b1 feedback loop modulates hypoxia-induced cell proliferation, invasion, and EMT in human osteosarcoma cells","volume":"119","author":"Wang","year":"2018","journal-title":"J. Cell Biochem."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Wang, L., Wu, J., Song, S., Chen, H., Hu, Y., Xu, B., and Liu, J. (2021). Plasma Exosome-Derived Sentrin SUMO-Specific Protease 1: A Prognostic Biomarker in Patients With Osteosarcoma. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.625109"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1002\/cam4.3830","article-title":"Long noncoding RNA MCM3AP-AS1 enhances cell proliferation and metastasis in colorectal cancer by regulating miR-193a-5p\/SENP1","volume":"10","author":"Zhou","year":"2021","journal-title":"Cancer Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.biopha.2018.10.071","article-title":"The SUMO-specific protease family regulates cancer cell radiosensitivity","volume":"109","author":"Hu","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e649","DOI":"10.1002\/ctm2.649","article-title":"Identification of potent SENP1 inhibitors that inactivate SENP1\/JAK2\/STAT signaling pathway and overcome platinum drug resistance in ovarian cancer","volume":"11","author":"Zhang","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1021\/acs.jnatprod.1c01166","article-title":"Discovery of Natural Ursane-type SENP1 Inhibitors and the Platinum Resistance Reversal Activity Against Human Ovarian Cancer Cells: A Structure-Activity Relationship Study","volume":"85","author":"Wei","year":"2022","journal-title":"J. Nat. Prod."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"113918","DOI":"10.1016\/j.ejmech.2021.113918","article-title":"Discovery and radiosensitization research of ursolic acid derivatives as SENP1 inhibitors","volume":"227","author":"Wei","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1124\/mol.118.112300","article-title":"Small-Molecule Inhibitors Targeting Protein SUMOylation as Novel Anticancer Compounds","volume":"94","author":"Yang","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Tokarz, P., and Wo\u017aniak, K. (2021). SENP Proteases as Potential Targets for Cancer Therapy. Cancers, 13.","DOI":"10.3390\/cancers13092059"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1080\/13543776.2022.2165910","article-title":"SUMO-specific protease 1 inhibitors-A literature and patent overview","volume":"32","author":"Li","year":"2022","journal-title":"Expert. Opin. Ther. Pat."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5382684","DOI":"10.1155\/2021\/5382684","article-title":"Kochiae Fructus, the Fruit of Common Potherb Kochia scoparia (L.) Schrad: A Review on Phytochemistry, Pharmacology, Toxicology, Quality Control, and Pharmacokinetics","volume":"2021","author":"Zou","year":"2021","journal-title":"Evid.-Based Complement. Alternat. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"58995","DOI":"10.18632\/oncotarget.10636","article-title":"Momordin Ic, a new natural SENP1 inhibitor, inhibits prostate cancer cell proliferation","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s10495-013-0820-z","article-title":"Momordin Ic induces HepG2 cell apoptosis through MAPK and PI3K\/Akt-mediated mitochondrial pathways","volume":"18","author":"Wang","year":"2013","journal-title":"Apoptosis"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1039\/c3fo60558b","article-title":"A novel mechanism for momordin Ic-induced HepG2 apoptosis: Involvement of PI3K- and MAPK-dependent PPAR\u03b3 activation","volume":"5","author":"Wang","year":"2014","journal-title":"Food Funct."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.tiv.2019.01.007","article-title":"Suppressive effects of Momordin Ic on HepG2 cell migration and invasion by regulating MMP-9 and adhesion molecules: Involvement of p38 and JNK pathways","volume":"56","author":"Wang","year":"2019","journal-title":"Toxicol. In Vitro"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"104784","DOI":"10.1016\/j.tiv.2020.104784","article-title":"Natural triterpenoid saponin Momordin Ic suppresses HepG2 cell invasion via COX-2 inhibition and PPAR\u03b3 activation","volume":"65","author":"Wang","year":"2020","journal-title":"Toxicol. In Vitro"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jphs.2021.04.007","article-title":"Momordin Ic induces G0\/1 phase arrest and apoptosis in colon cancer cells by suppressing SENP1\/c-MYC signaling pathway","volume":"146","author":"Xianjun","year":"2021","journal-title":"J. Pharmacol. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"10983","DOI":"10.1073\/pnas.1802932115","article-title":"SUMO protease SENP1 deSUMOylates and stabilizes c-Myc","volume":"115","author":"Sun","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.freeradbiomed.2015.11.022","article-title":"Momordin Ic couples apoptosis with autophagy in human hepatoblastoma cancer cells by reactive oxygen species (ROS)-mediated PI3K\/Akt and MAPK signaling pathways","volume":"90","author":"Mi","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"5522164","DOI":"10.1155\/2021\/5522164","article-title":"Kochia scoparia Saponin Momordin Ic Modulates HaCaT Cell Proliferation and Apoptosis via the Wnt\/\u03b2-Catenin Pathway","volume":"2021","author":"Luo","year":"2021","journal-title":"Evid.-Based Complement. Alternat. Med."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Gayathri, K.G., Shinde, P.L., John, S., Sivakumar, K.C., and Mishra, R. (2023). Understanding the Combined Effects of High Glucose Induced Hyper-Osmotic Stress and Oxygen Tension in the Progression of Tumourigenesis: From Mechanism to Anti-Cancer Therapeutics. Cells, 12.","DOI":"10.3390\/cells12060825"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41419-021-03635-6","article-title":"SENP1-mediated deSUMOylation of JAK2 regulates its kinase activity and platinum drug resistance","volume":"12","author":"Li","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Zhang, Y., Shen, Y., Wei, W., Wang, W., Jiang, D., Ren, Y., Peng, Z., Fan, Q., Cheng, J., and Ma, J. (2022). Dysregulation of SIRT3 SUMOylation Confers AML Chemoresistance via Controlling HES1-Dependent Fatty Acid Oxidation. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23158282"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s13659-021-00298-w","article-title":"Hinokiflavone and Related C-O-C-Type Biflavonoids as Anti-cancer Compounds: Properties and Mechanism of Action","volume":"11","author":"Goossens","year":"2021","journal-title":"Nat. Prod. Bioprospect."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jmgm.2013.12.008","article-title":"Discovery of potent inhibitor for matrix metalloproteinase-9 by pharmacophore based modeling and dynamics simulation studies","volume":"49","author":"Kalva","year":"2014","journal-title":"J. Mol. Graph. Model."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1111\/jgh.14581","article-title":"Antitumor activity in colorectal cancer induced by hinokiflavone","volume":"34","author":"Zhou","year":"2019","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Ilic, V.K., Egorova, O., Tsang, E., Gatto, M., Wen, Y., Zhao, Y., and Sheng, Y. (2022). Hinokiflavone Inhibits MDM2 Activity by Targeting the MDM2-MDMX RING Domain. Biomolecules, 12.","DOI":"10.3390\/biom12050643"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e27402","DOI":"10.7554\/eLife.27402","article-title":"Characterisation of the biflavonoid hinokiflavone as a pre-mRNA splicing modulator that inhibits SENP","volume":"6","author":"Pawellek","year":"2017","journal-title":"eLife"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13045-021-01079-1","article-title":"Targeting MCL-1 in cancer: Current status and perspectives","volume":"14","author":"Wang","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Hsieh, T.H., Kuo, H.P., Chen, M.C., Lin, Y.C., Lin, B.J., Hsu, K.C., and Chen, C.H. (2025). Hinokiflavone is a novel CK2 inhibitor promoting apoptosis and synergizing with chemotherapeutic agents in cisplatin resistant bladder cancer cells. Sci. Rep., 15.","DOI":"10.1038\/s41598-025-06543-3"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1158\/0008-5472.CAN-22-4017","article-title":"SENP1 Decreases RNF168 Phase Separation to Promote DNA Damage Repair and Drug Resistance in Colon Cancer","volume":"83","author":"Wei","year":"2023","journal-title":"Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"973","DOI":"10.7150\/thno.79688","article-title":"Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancer","volume":"13","author":"Zhang","year":"2023","journal-title":"Theranostics"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Huang, W., He, T., Chai, C., Yang, Y., Zheng, Y., Zhou, P., Qiao, X., Zhang, B., Liu, Z., and Wang, J. (2012). Triptolide inhibits the proliferation of prostate cancer cells and down-regulates SUMO-specific protease 1 expression. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0037693"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3892\/mmr.2022.12904","article-title":"Triptolide promotes ferroptosis by suppressing Nrf2 to overcome leukemia cell resistance to doxorubicin","volume":"27","author":"Wu","year":"2023","journal-title":"Mol. Med. Rep."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Li, X., Shan, Y., Wang, S., Wang, J., and Heng, X. (2024). Triptolide induces apoptosis of glioma cells by inhibiting NF-\u03baB activation during oxidative stress. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-80856-7"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Gorrie, D., Bravo, M., and Fan, L. (2024). The Yin and Yang of the Natural Product Triptolide and Its Interactions with XPB, an Essential Protein for Gene Expression and DNA Repair. Genes, 15.","DOI":"10.3390\/genes15101287"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e24335","DOI":"10.1016\/j.heliyon.2024.e24335","article-title":"Mechanisms of cancer cell death induction by triptolide: A comprehensive overview","volume":"10","author":"Feng","year":"2024","journal-title":"Heliyon"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Wang, G., Guo, H., Ren, Y., Chen, W., Wang, Y., Li, J., Liu, H., Xing, J., Zhang, Y., and Li, N. (2023). Triptolide enhances carboplatin-induced apoptosis by inhibiting nucleotide excision repair (NER) activity in melanoma. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1157433"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2231765","DOI":"10.1080\/16078454.2023.2231765","article-title":"The roles of TPL in hematological malignancies","volume":"28","author":"Xu","year":"2023","journal-title":"Hematology"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Li, M., Li, J., Tang, Q., and Zhu, Y. (2024). Potential antitumor activity of triptolide and its derivatives: Focused on gynecological and breast cancers. Biomed. Pharmacother., 180.","DOI":"10.1016\/j.biopha.2024.117581"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1128\/MCB.24.13.6021-6028.2004","article-title":"SENP1 enhances androgen receptor-dependent transcription through desumoylation of histone deacetylase 1","volume":"24","author":"Cheng","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"156ra139","DOI":"10.1126\/scitranslmed.3004334","article-title":"A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer","volume":"4","author":"Chugh","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1158\/0008-5472.CAN-21-4222","article-title":"Pharmacologic Targeting of TFIIH Suppresses KRAS-Mutant Pancreatic Ductal Adenocarcinoma and Synergizes with TRAIL","volume":"82","author":"Moser","year":"2022","journal-title":"Cancer Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"12035","DOI":"10.1002\/anie.201606121","article-title":"Targeted Delivery and Sustained Antitumor Activity of Triptolide through Glucose Conjugation","volume":"55","author":"He","year":"2016","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"101536","DOI":"10.1016\/j.isci.2020.101536","article-title":"A Glucose-Triptolide Conjugate Selectively Targets Cancer Cells under Hypoxia","volume":"23","author":"Datan","year":"2020","journal-title":"iScience"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"101900","DOI":"10.1016\/j.toxrep.2025.101900","article-title":"Recent developments on ursolic acid and its potential biological applications","volume":"14","author":"Arulnangai","year":"2025","journal-title":"Toxicol. Rep."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1080\/13543776.2017.1344219","article-title":"Ursolic acid derivatives for pharmaceutical use: A patent review (2012-2016)","volume":"27","author":"Hussain","year":"2017","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1080\/10408398.2016.1203755","article-title":"Ursolic acid, a potential anticancer compound for breast cancer therapy","volume":"58","author":"Yin","year":"2018","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Michalak, O., Cybulski, M., Kubiszewski, M., Finiuk, N., Kozak, Y., Milenkovic, D., \u017burawicka, S., Roszczenko, P., Bielawska, A., and Trzaskowski, B. (2025). Uracil derivatives\/ursolic acid hybrids\u2014Naturally derived compounds as anticancer agents. Sci. Rep., 15.","DOI":"10.1038\/s41598-025-14351-y"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Similie, D., Minda, D., Bora, L., Kro\u0161kins, V., Lugi\u0146ina, J., Turks, M., Dehelean, C.A., and Danciu, C. (2024). An Update on Pentacyclic Triterpenoids Ursolic and Oleanolic Acids and Related Derivatives as Anticancer Candidates. Antioxidants, 13.","DOI":"10.3390\/antiox13080952"},{"key":"ref_62","first-page":"881","article-title":"An evaluation of actinomycin D and mitomycin C in patients with advanced cancer","volume":"50","author":"Humphrey","year":"1961","journal-title":"Surgery"},{"key":"ref_63","first-page":"27","article-title":"Clinical Effects of Prolonged (Continuous) Infusion of Streptonigrin (Nsc-45383) in Advanced Cancer","volume":"33","author":"Sullivan","year":"1963","journal-title":"Cancer Chemother. Rep."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/1097-0142(196501)18:1<49::AID-CNCR2820180109>3.0.CO;2-#","article-title":"Chemotherapy with Streptonigrin in Advanced Cancer","volume":"18","author":"Harris","year":"1965","journal-title":"Cancer"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Sztiller-Sikorska, M., Koprowska, K., Majchrzak, K., Hartman, M., and Czyz, M. (2014). Natural compounds\u2019 activity against cancer stem-like or fast-cycling melanoma cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0090783"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1021\/cb400177q","article-title":"Identification and characterization of a new chemotype of noncovalent SENP inhibitors","volume":"8","author":"Madu","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1021\/acs.biochem.7b00947","article-title":"Streptonigrin Inhibits SENP1 and Reduces the Protein Level of Hypoxia-Inducible Factor 1alpha (HIF1alpha) in Cells","volume":"57","author":"Ambaye","year":"2018","journal-title":"Biochemistry"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1052102","DOI":"10.1155\/2018\/1052102","article-title":"Vialinin A, an Edible Mushroom-Derived p-Terphenyl Antioxidant, Prevents VEGF-Induced Neovascularization In Vitro and In Vivo","volume":"2018","author":"Sonowal","year":"2018","journal-title":"Oxid. Med. Cell Longev."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1271\/bbb.69.2326","article-title":"Vialinin A, a novel 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenger from an edible mushroom in China","volume":"69","author":"Xie","year":"2005","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/jcmm.16180","article-title":"Ubiquitously specific protease 4 inhibitor-Vialinin A attenuates inflammation and fibrosis in S100-induced hepatitis mice through Rheb\/mTOR signalling","volume":"25","author":"Xu","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1248\/bpb.31.831","article-title":"Vialinin A, a novel potent inhibitor of TNF-alpha production from RBL-2H3 cells","volume":"31","author":"Onose","year":"2008","journal-title":"Biol. Pharm. Bull."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"155304","DOI":"10.1016\/j.phymed.2023.155304","article-title":"Vialinin A alleviates oxidative stress and neuronal injuries after ischaemic stroke by accelerating Keap1 degradation through inhibiting USP4-mediated deubiquitination","volume":"124","author":"Mao","year":"2024","journal-title":"Phytomedicine"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Yoshioka, Y., Ye, Y.Q., Okada, K., Taniguchi, K., Yoshida, A., Sugaya, K., Onose, J., Koshino, H., Takahashi, S., and Yajima, A. (2013). Ubiquitin-specific peptidase 5, a target molecule of vialinin A, is a key molecule of TNF-alpha production in RBL-2H3 cells. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0080931"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Bailly, C. (2022). Anti-inflammatory and anticancer p-terphenyl derivatives from fungi of the genus Thelephora. Bioorg. Med. Chem., 70.","DOI":"10.1016\/j.bmc.2022.116935"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"11795549241281932","DOI":"10.1177\/11795549241281932","article-title":"Unraveling the Mechanism of Action of Ubiquitin-Specific Protease 5 and Its Inhibitors in Tumors","volume":"18","author":"Wang","year":"2024","journal-title":"Clin. Med. Insights Oncol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1016\/j.bmcl.2016.07.051","article-title":"Vialinin A and thelephantin G, potent inhibitors of tumor necrosis factor-alpha production, inhibit sentrin\/SUMO-specific protease 1 enzymatic activity","volume":"26","author":"Yoshioka","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2174\/1871520621666211119085834","article-title":"Gallic Acid: A Dietary Polyphenol that Exhibits Anti-neoplastic Activities by Modulating Multiple Oncogenic Targets","volume":"22","author":"Tuli","year":"2022","journal-title":"Anticancer Agents Med. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1080\/07391102.2021.1880480","article-title":"Identification of novel anti-cancer agents, applying in silico method for SENP1 protease inhibition","volume":"40","author":"Taghvaei","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Taghvaei, S., Taghvaei, A., Anvar, M.S., Guo, C., Sabouni, F., and Minuchehr, Z. (2023). Computational study of SENP1 in cancer by novel natural compounds and ZINC database screening. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1144632"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Yan, T., Wang, Y., Hou, Z., Song, P., Wang, P., Li, J., Zheng, J., and Lv, D. (2025). A comprehensive overview of triptolide utilizing nanotechnology and its potential applications in prostate diseases. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1592066"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/22\/11210\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T09:49:24Z","timestamp":1763632164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/22\/11210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":80,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["ijms262211210"],"URL":"https:\/\/doi.org\/10.3390\/ijms262211210","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]}}}